This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

High-speed atomic force microscopy reveals processes relevant to Alzheimer's disease

Zooming in on neurotoxic aggregates
High-speed atomic force microscopy and schematic visualization of protofibrils — dynamics, binding, dissociation and biochemical interactions. Credit: American Chemical Society

Researchers at Kanazawa University report in Nano Letters how high-speed atomic force microscopy leads to insights into processes relevant to Alzheimer's disease. Moreover, the technique is shown to be an excellent tool for studying the effect of drugs against the disease.

According to the , Alzheimer's disease—the most common type of dementia—is caused by flaws in the production, accumulation, and disposal of amyloid-beta (Aβ) in the brain. Aβ refers to a group of peptides (protein fragments) that over time form plaques in the brain of people with Alzheimer's disease. Drugs aiming to reduce the aggregation of Aβ have been developed, but recent findings show that different types of Aβ aggregates have different contributions to the development of Alzheimer's disease.

In particular, intermediate aggregates such as protofibrils are more toxic than the actual final fibrils, the main component of Aβ plaques. A precise understanding of the complex aggregation pathways is therefore necessary for the further development of efficient drugs against Alzheimer's disease. Kenjiro Ono from Kanazawa University and colleagues have now succeeded in visualizing the structural dynamics of protofibrils, as well as the effect of a recently developed based on anti-Aβ antibodies.

HS-AFM movie of Aβ42 PF on bare mica. Credit: Nano Letters (2023). DOI: 10.1021/acs.nanolett.3c00187

The scientists looked at the formation and the structure of Aβ protofibrils by means of high-speed (HS-AFM). The latter method has in recent years emerged as a powerful nanoimaging tool for studying biomolecules and their dynamics at high spatiotemporal resolution. HS-AFM observations showed that protofibrils have a nodal structure, with stable structural features—specifically, the binding angle between nodes—across several samples. Importantly, this nodal structure is distinct from proper, mature fibrils, which have a helical structure.

Ono and colleagues then investigated the dissociation of protofibrils. They found that the length of protofibrils depends on their concentration, suggesting that aggregates can dissociate spontaneously.

To obtain detailed insights into the functioning of anti-Aβ antibody drugs, the researchers examined the binding between Aβ protofibrils and a new drug known as lecanemab. They found that the binding ability (affinity) of lecanemab for protofibrils is almost independent of the size of the protofibrils—in other words, the affinity does not substantially vary throughout the aggregation process. HS-AFM observations further revealed that lecanemab covers the surface of small, pre-protofibril aggregates. In doing so, the drug inhibits the further aggregation into protofibrils, which in turn prevents the formation of proper Aβ fibrils and plaques.

The results of Ono and colleagues provide direct evidence of a mechanism through which an antibody drug interferes with the Aβ aggregation process. More generally, the work confirms the versatility of the HS-AFM method for studying biochemical pathways. "Single-molecule HS-AFM is an effective tool for revealing the structural dynamics of transient, metastable amyloid aggregation intermediates and the effects of anti-aggregating drugs on them," state the researchers.

High-speed atomic force microscopy

The general principle of atomic force microscopy (AFM) is to make a very small tip scan the surface of a sample. During this horizontal (xy) scan, the tip, which is attached to a small cantilever, follows the sample's vertical (z) profile, inducing a force on the cantilever that can be measured. The magnitude of the force at the xy position can be related to the z value; the xyz data generated during a scan then result in a height map providing structural information about the investigated sample. In high-speed-AFM (HS-AFM), the working principle is slightly more involved: the cantilever is made to oscillate near its . When the tip is moved around a surface, the variations in the amplitude (or the frequency) of the cantilever's oscillation—resulting from the tip's interaction with the sample's surface—are recorded, as these provide a measure for the local "z" value.

HS-AFM results in a video, where the between frames depends on the speed with which a can be generated (by xy-scanning the sample). Researchers at Kanazawa University have in recent years developed HS-AFM further, so that it can be applied to study biochemical molecules and biomolecular processes in real-time. Kenjiro Ono and colleagues have now applied the method to study the structural dynamics of amyloid-beta protofibrils, known to play a crucial role in the pathogenesis of Alzheimer's disease, as well as the effect of an anti-amyloid-beta antibody drug against the disease.

More information: Takahiro Watanabe-Nakayama et al, Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy, Nano Letters (2023). DOI: 10.1021/acs.nanolett.3c00187

Journal information: Nano Letters

Citation: High-speed atomic force microscopy reveals processes relevant to Alzheimer's disease (2023, May 16) retrieved 21 April 2024 from https://phys.org/news/2023-05-high-speed-atomic-microscopy-reveals-relevant.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA-approved Alzheimer's drug lecanemab could prevent free-floating amyloid beta fibrils from damaging the brain

65 shares

Feedback to editors